Why J&J thinks its new psoriasis pill could be one of its biggest drugs ever
Investors are counting drugs like Icotyde to accelerate J&J’s revenue growth rate.
A state banquet, selfies with Musk and Huang’s noodle run: The spectacle of Trump’s Beijing visit
The visit was full of friendly overtures, orchestrated pageantry, business dealmaking, and headline-grabbing sideshows.
Russia’s Putin to meet China’s Xi in Beijing from May 19-20, Beijing and Moscow say
Putin’s trip follows shortly after U.S. President Donald Trump’s visit to Beijing.
Why Taiwan became the defining issue in the Trump-Xi talks
U.S. President Donald Trump had said arms sales to Taiwan would be on the agenda for his talks with Chinese President Xi Jinping which ended Friday.
From train travel to staycations: How holidaymakers are adapting to airlines’ jet fuel shortage
“I think people will increasingly decide, let’s book Portugal, Spain, Italy… let’s avoid the Middle East or going long haul,” Ryanair’s CEO told CNBC.
From train travel to staycations: How holidaymakers are adapting to airlines’ jet fuel shortage
“I think people will increasingly decide, let’s book Portugal, Spain, Italy… let’s avoid the Middle East or going long haul,” Ryanair’s CEO told CNBC.
How global CEOs are navigating rising costs and supply chain disruption
Christine Tan speaks with Roger Lee of TAL Apparel, Dr Prem Kumar Nair of IHH Healthcare and Michael Mertin of AT&S about how rising energy costs, shipping volatility and supply chain bottlenecks are affecting their businesses. The executives discuss w…
AI chip bubble rivals French stocks in 1700s, surpasses Nasdaq during dot-com frenzy by one measure
Historical parallels for the artificial intelligence bubble are in no short supply.
Chinese EVs are coming to Canada, and some dealers can’t wait to sell them
Canada is allowing 49,000 Chinese-made electric vehicles to be imported for retail sales annually at a tariff rate of 6.1%.
Bristol Myers Squibb turns to China to develop new drugs in newest cross-continent collaboration
U.S. drugmaker Bristol Myers Squibb inked a partnership with a Chinese company that some say could mark the next wave of collaboration across continents.
